Fast-Tracked Medications More Likely To Face Later Regulatory Action To Remedy Safety Concerns

Many medications are approved by the U.S. Food and Drug Administration on the brink of congressionally mandated deadlines, and those drugs are more likely to face later regulatory intervention than those approved with greater deliberation, researchers at Harvard University have found.

More: continued here

Filed under: Pharma Industry on April 2nd, 2008